US News and World Report: Differences in how cardio and strength affect your health
UC cardiologist offers thoughts on exercise and cardiovascular health
The debate over which is best, cardio or strength training, is an ongoing one among exercise enthusiasts. But the two aren’t really mutually exclusive, say health expert. For most people, how much time you should devote to cardiovascular forms of exercise versus resistance training depends on what you enjoy most in your fitness routine.
Dr. Richard Becker, director of the UC Heart, Lung and Vascular Institute, cautioned if you are about to start weight training, it is best not to begin with heavy weights or resistance that can tire or injure muscles or joints. Some exercises that are good for type 2 muscle fibers and serve as alternatives include hiking, running, swimming laps, heavy yard work, cycling and cross-country skiing.
Check out the full story online.
Dr. Becker has also been interviewed by other media, including the New York Times, for his expertise on age and bypass surgery for heart attack patients.
Related Stories
Is a colonoscopy painful?
May 13, 2026
The University of Cincinnati's Susan Kais, MD, assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology in the College of Medicine and UC Health gastroenterologist, recently appeared on the ARC Cincinnati morning program on Local 12/WKRC-TV to answer common questions from viewers about colonoscopies and to dispel myths.
University of Cincinnati graduate programs rise in national rankings across high-demand fields
May 13, 2026
University of Cincinnati graduate programs climbed in the latest U.S. News & World Report rankings, led by strong gains in workforce-focused fields including public health, clinical psychology and business.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.